ESPL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, in a subset of patients with chronic myeloid leukemia (CML), enhanced proteolytic activity of separase has been found to correlate with clonal evolution and accelerated transformation from chronic phase (hyperplasia) to blast crisis suggesting a role as driver for leukemia progression [30].